Literature DB >> 17568772

Negative regulation of SEK1 signaling by serum- and glucocorticoid-inducible protein kinase 1.

Myung Jin Kim1, Ji Soo Chae, Kwang Je Kim, Sang Gil Hwang, Kyoung Wan Yoon, Eun Kyung Kim, Hee Jae Yun, Jun-Ho Cho, Jeehyun Kim, Bong-Woo Kim, Hyung-Chul Kim, Sang Sun Kang, Florian Lang, Ssang-Goo Cho, Eui-Ju Choi.   

Abstract

Serum- and glucocorticoid-inducible protein kinase 1 (SGK1) has been implicated in diverse cellular activities including the promotion of cell survival. The molecular mechanism of the role of SGK1 in protection against cellular stress has remained unclear, however. We have now shown that SGK1 inhibits the activation of SEK1 and thereby negatively regulates the JNK signaling pathway. SGK1 was found to physically associate with SEK1 in intact cells. Furthermore, activated SGK1 mediated the phosphorylation of SEK1 on serine 78, resulting in inhibition of the binding of SEK1 to JNK1, as well as to MEKK1. Replacement of serine 78 of SEK1 with alanine abolished SGK1-mediated SEK1 inhibition. Oxidative stress upregulated SGK1 expression, and depletion of SGK1 by RNA interference potentiated the activation of SEK1 induced by oxidative stress in Rat2 fibroblasts. Moreover, such SGK1 depletion prevented the dexamethasone-induced increase in SGK1 expression, as well as the inhibitory effects of dexamethasone on paclitaxel-induced SEK1-JNK signaling and apoptosis in MDA-MB-231 breast cancer cells. Together, our results suggest that SGK1 negatively regulates stress-activated signaling through inhibition of SEK1 function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17568772      PMCID: PMC1914103          DOI: 10.1038/sj.emboj.7601755

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  42 in total

1.  Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum.

Authors:  M K Webster; L Goya; Y Ge; A C Maiyar; G L Firestone
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

2.  Immediate-early transcriptional regulation and rapid mRNA turnover of a putative serine/threonine protein kinase.

Authors:  M K Webster; L Goya; G L Firestone
Journal:  J Biol Chem       Date:  1993-06-05       Impact factor: 5.157

3.  Differential expression of sgk mRNA, a member of the Ser/Thr protein kinase gene family, in rat brain after CNS injury.

Authors:  K Imaizumi; M Tsuda; A Wanaka; M Tohyama; T Takagi
Journal:  Brain Res Mol Brain Res       Date:  1994-10

Review 4.  Serum and glucocorticoid-regulated protein kinases: variations on a theme.

Authors:  Maude Tessier; James R Woodgett
Journal:  J Cell Biochem       Date:  2006-08-15       Impact factor: 4.429

5.  Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer.

Authors: 
Journal:  N Engl J Med       Date:  1995-01-05       Impact factor: 91.245

6.  Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun.

Authors:  I Sánchez; R T Hughes; B J Mayer; K Yee; J R Woodgett; J Avruch; J M Kyriakis; L I Zon
Journal:  Nature       Date:  1994 Dec 22-29       Impact factor: 49.962

7.  The serum- and glucocorticoid-induced kinase SGK inhibits mutant huntingtin-induced toxicity by phosphorylating serine 421 of huntingtin.

Authors:  Hélène Rangone; Ghislaine Poizat; Juan Troncoso; Christopher A Ross; Marcy E MacDonald; Frédéric Saudou; Sandrine Humbert
Journal:  Eur J Neurosci       Date:  2004-01       Impact factor: 3.386

8.  Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury.

Authors:  Péter Hamar; Erwei Song; Gabor Kökény; Allen Chen; Nengtai Ouyang; Judy Lieberman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-04       Impact factor: 11.205

9.  Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells.

Authors:  Wei Wu; Shamita Chaudhuri; Deanna R Brickley; Diana Pang; Theodore Karrison; Suzanne D Conzen
Journal:  Cancer Res       Date:  2004-03-01       Impact factor: 12.701

10.  Identification of a novel antiapoptotic protein that antagonizes ASK1 and CAD activities.

Authors:  Ssang-Goo Cho; Jin Woo Kim; Yong Hee Lee; Hyun Sub Hwang; Mi-Sung Kim; Kanghyun Ryoo; Myung Jin Kim; Kyung Tae Noh; Eun Kyung Kim; Jun-Ho Cho; Kyoung Wan Yoon; Eun-Gyung Cho; Hee-Sae Park; Sung Wook Chi; Min-Jae Lee; Sang Sun Kang; Hidenori Ichijo; Eui-Ju Choi
Journal:  J Cell Biol       Date:  2003-10-13       Impact factor: 10.539

View more
  23 in total

1.  RASSF7 negatively regulates pro-apoptotic JNK signaling by inhibiting the activity of phosphorylated-MKK7.

Authors:  S Takahashi; A Ebihara; H Kajiho; K Kontani; H Nishina; T Katada
Journal:  Cell Death Differ       Date:  2010-11-19       Impact factor: 15.828

Review 2.  The Two Faces of Adjuvant Glucocorticoid Treatment in Ovarian Cancer.

Authors:  Vladimir Djedovic; Yoo-Young Lee; Alexandra Kollara; Taymaa May; Theodore J Brown
Journal:  Horm Cancer       Date:  2018-01-08       Impact factor: 3.869

Review 3.  Targeting innate immunity protein kinase signalling in inflammation.

Authors:  Matthias Gaestel; Alexey Kotlyarov; Michael Kracht
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694

4.  Oncogenic Ras differentially regulates metabolism and anoikis in extracellular matrix-detached cells.

Authors:  J A Mason; C A Davison-Versagli; A K Leliaert; D J Pape; C McCallister; J Zuo; S M Durbin; C L Buchheit; S Zhang; Z T Schafer
Journal:  Cell Death Differ       Date:  2016-02-26       Impact factor: 15.828

Review 5.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

6.  Serum- and Glucocorticoid-Inducible Kinase 1 Confers Protection in Cell-Based and in In Vivo Neurotoxin Models via the c-Jun N-Terminal Kinase Signaling Pathway.

Authors:  Sarah Iqbal; Shannon Howard; Philip V LoGrasso
Journal:  Mol Cell Biol       Date:  2015-03-30       Impact factor: 4.272

7.  Serum- and glucocorticoid-inducible kinase 1 activity reduces dendritic spines in dorsal hippocampus.

Authors:  Emily E Steffke; Deniz Kirca; Michelle S Mazei-Robison; Alfred J Robison
Journal:  Neurosci Lett       Date:  2020-03-10       Impact factor: 3.046

8.  Serum- and glucocorticoid-regulated kinase 1 is required for nuclear export of the ribonucleoprotein of influenza A virus.

Authors:  Judith G Alamares-Sapuay; Luis Martinez-Gil; Silke Stertz; Matthew S Miller; Megan L Shaw; Peter Palese
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

Review 9.  Targeting SGK1 in diabetes.

Authors:  Florian Lang; Agnes Görlach; Volker Vallon
Journal:  Expert Opin Ther Targets       Date:  2009-11       Impact factor: 6.902

10.  Administration of glucocorticoids to ovarian cancer patients is associated with expression of the anti-apoptotic genes SGK1 and MKP1/DUSP1 in ovarian tissues.

Authors:  Amal Melhem; S Diane Yamada; Gini F Fleming; Bertha Delgado; Deanna R Brickley; Wei Wu; Masha Kocherginsky; Suzanne D Conzen
Journal:  Clin Cancer Res       Date:  2009-04-21       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.